Correction of the dystrophic phenotype by germ-line gene therapy with recombinant dystrophin cDNAs in mdx mice.
Wells
D J
DJ
Department of Pharmacology, Charing Cross & Westminster Medical School, London, U.K.
Dickson
G
G
Wells
K E
KE
D000375:Aging; D000818:Animals; D018076:DNA, Complementary; D016189:Dystrophin / Q000096:biosynthesis / Q000235:genetics*; D015870:Gene Expression; D006801:Humans; D007527:Isoenzymes / Q000096:biosynthesis; D051379:Mice; D018101:Mice, Inbred mdx; D008822:Mice, Transgenic; D024510:Muscle Development; D018482:Muscle, Skeletal / Q000166:cytology / Q000254:growth & development; D009137:Muscular Dystrophy, Animal / Q000235:genetics / Q000503:physiopathology / Q000628:therapy*; D019001:Nitric Oxide Synthase / Q000096:biosynthesis; D011994:Recombinant Proteins / Q000096:biosynthesis; D012016:Reference Values; D012508:Sarcolemma / Q000201:enzymology
D018076:DNA, Complementary; D016189:Dystrophin; D007527:Isoenzymes; D011994:Recombinant Proteins; D019001:Nitric Oxide Synthase